Coverage
-
January 06, 2015
A Massachusetts federal judge on Tuesday ruled that Axis Reinsurance doesn't have a duty to defend BioChemics Inc. in U.S. Securities and Exchange Commission subpoenas and an SEC enforcement action, because its claim was made before directors and officers coverage went into effect.
2 other articles on this case.
View all »